Peyman Ghorbani retweeted
Immunology takes center stage again at the #NobelPrize! Congratulations to Mary Brunkow, Fred Ramsdell & Shimon Sakaguchi for uncovering how regulatory T cells maintain immune tolerance—a discovery that transformed our understanding of autoimmunity and cancer immunotherapy
Peyman Ghorbani retweeted
A nitroalkene derivative of salicylate, SANA, induces creatine-dependent thermogenesis and promotes weight loss go.nature.com/3SZcRDD
Peyman Ghorbani retweeted
I am thrilled to share that our recent study on the development of a metabolic gene function discovery platform is now online on Nature Genetics. nature.com/articles/s41588-0….
Peyman Ghorbani retweeted
🆕 In this study, @Immunometabolab @dr_p_g @cfongmcmaster et al sought to validate the significance of the AMPK-HMGCR signaling axis in atherosclerosis using a non-germline hypercholesterolemia model with functional ApoE
🔗atherosclerosis-journal.com/…
@society_eas #CvPrev #EASSoMe
Peyman Ghorbani retweeted
Did you know that 28 out of 34 signalling pathways, and ~60% of the proteome, respond differently depending on the metal ion environment? Neither did we, but now believe that the metal ion levels are one of the big "known unknowns" in cellular networks biorxiv.org/content/10.1101/…
Peyman Ghorbani retweeted
📢 #ImmunoMetaLovers!
Passionated about ImmunoMetabolism?
Ready to dive into the latest discoveries & tech advances with like-minded experts?💡
1st ever European ImmunoMetabolism Network "Metabolism Meets Immunology" conference
📅 26-28 June
@ImmunoMetEurope for ++
🙏Share! – at Marseille, France
Peyman Ghorbani retweeted
New Insights: @IsabelUlmert and @katha_lahl @UCalgary @DTUtweet discuss new work from Ohara et al. (hubs.la/Q02frJMb0) that provides clarity on the much-debated question of which cells produce IL-23 in the gut. hubs.la/Q02frKMC0
Peyman Ghorbani retweeted
Beautiful work by our collaborator @HiteLabMSKCC determining the structural basis of Flvcr1-mediated transport. Single mutation can uncouple choline and ethanolamine transport. @RockefellerUniv @MSKCancerCenter biorxiv.org/content/10.1101/…
Structural bio - more evidence that FLVCR1 and 2 are choline transporters. Supports the reports from @KivancBirsoy & Hamachi labs. Interesting in the context of our work with macrophages! Congrats 🏆 @th_weng @safarianschara
biorxiv.org/content/10.1101/…
Peyman Ghorbani retweeted
Congrats to Julia and the team (@TKT_Smith @dr_p_g @KilgourMarisa @NatashaTrza to name a few)🍻! This took a few turns but happy to report the findings. Thorough comparison of ♀️& ♂ mice, with ♀️ liver responses trending higher. @uOttawaBMI @uOttawaCI3 @UOHIResearch @CIHR_IRSC
Does #ThermoneutralHousing & consumption of a classical #WesternDiet worsen metabolic dysfunction-associated fatty liver disease in mice? More in @AJPEndoMetab from Nunes et al. @NatashaTrza @Immunometabolab
ow.ly/rQlo50OqZxC
@uOttawaMed #MAFLD #Obesity #MouseModel
Peyman Ghorbani retweeted
Our latest paper on the development of new fluorescent Golgi stains is out in ACS Chem Biol! Our "palmitoylation-dependent fluorescent probes" are simple to use and can stain live-cell Golgi with higher specificities than existing ceramide-based probes✨🔬
pubs.acs.org/doi/10.1021/acs…
Peyman Ghorbani retweeted
🚨To all macrophage & dendritic cell fans. Last time we organised a VIB Myeloid cell meeting we were completely sold-out within weeks. So just a warning to register in time for the #EMDS23 conference! vibconferences.be/events/emd…. Speaker list is fantastic 🤩🤩🤩. Please retweet 🙏🏼
Peyman Ghorbani retweeted
#LaskerLaureate Ralph Steinman discovered #dendriticcells (DCs). Now, researchers show that a subpopulation, CD5+ DCs, enhance T cell priming and are associated with better prognosis in several types of #cancer. @klechevskyLab
ow.ly/3hjw50MZCNl
Peyman Ghorbani retweeted
To follow up on our previous post: all our #flowpostit about #controls you can find here:
bitly.pl/EmiG4
Go check it out, easy and fast(!) way to learn good #flowcytometry !
#flowedu #flowcyto
Peyman Ghorbani retweeted
Honoured and thankful to receive @DiabetesCanada funding to further our understanding of cell death pathways and inflammation in diabetes. Hugely thankful for our partners @PepperLab_UofA @bruinjenny1 and Dr. Erin Mulvihill! Congrats to all recipients! @uOttawaMed @uOttawaBMI
We're thrilled to award $9M to 30 new research projects. Diabetes Canada funds some of the most renowned researchers in their quest for new developments in diabetes management, care, and risk-reduction that could lead to the next breakthrough. ow.ly/nb0Z50MsyWu
Peyman Ghorbani retweeted
Liver Seminar: Lipotoxicity in adipose tissue macrophage as link between obesity and its complications
👨🔬 Guillaume Bidault
📆 18/01
🕰️ 16:00
👉ow.ly/Urgu50Mno8x @LiverSeminars / @TVPLab
Peyman Ghorbani retweeted
Happy 2023! Join #TheMyeloidNetwork on Thursday 1/12 for our 1st seminar of the year! Dr. Alberto Mantovani will present "Macrophage Diversity and Plasticity In Cellular and Humoral Innate Immunity". We have a NEW ZOOM LINK that you can find on our website:themyeloidnetwork.eng.ucsd.e…
Heads up! Macrophages influence DC (and their own) metabolism through nitric oxide. A cautionary tale for GM-CSF-derived DC cultures!
Check out the paper by Lucía @luminarrieta and Janet from the Berod lab @luberod
onlinelibrary.wiley.com/doi/…
7
677
Peyman Ghorbani retweeted
Hey Twitter!
Don’t miss on our interview of @Immunometabolab about his recent #advances in the field of #Atherosclerosis!
#listen: https://nitter.cf/t.co/4mFYeTSI6o
@EmilioIAlarcon1, @uOttawaTMM, @uOttawaBMI,
@uOttawaMed, @INTBIOTECH_CAN, and
@BEaTSResearch
#Immunometabolism #SciComm – at Ottawa, Ontario





























